What one share of Acurx Pharmaceuticals holds
Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections.
Acurx Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.79 |
|---|---|
| Cash and investments | $2.28 |
| Book value | $1.74 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$14.86 | — | — | — | $8.73 |
| 2021 | — | −$29.87 | — | — | — | $24.30 |
| 2022 | — | −$22.36 | — | — | — | $12.58 |
| 2023 | — | −$23.01 | — | — | — | $6.45 |
| 2024 | — | −$17.45 | — | — | — | $0.72 |
| 2025 | — | −$5.32 | — | — | — | $2.24 |
Common questions about Acurx Pharmaceuticals
How much does one share of Acurx Pharmaceuticals earn?
Over the last 12 months, Acurx Pharmaceuticals lost $2.79 for each share.
Does Acurx Pharmaceuticals pay a dividend?
Acurx Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Acurx Pharmaceuticals’s book value per share?
Acurx Pharmaceuticals’s book value is $1.74 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Acurx Pharmaceuticals have?
Each share of Acurx Pharmaceuticals has $2.28 of cash and investments, as of June 30, 2026.
Has Acurx Pharmaceuticals bought back shares?
Acurx Pharmaceuticals’s share count rose about 384% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.